Medtronic Inc.

Headquarters location: 710 Medtronic Parkway N.E. Minneapolis, MN 55432 Tel. 763 514-4000 Job offers, investor relations: www.medtronic.com Email: webmaster@medtronic.com Stock:

Medtronic belongs to shareholder country     % source AXA 3.3 Barclays Plc 3.3 FMR Corp. (Fidelity Investments) 3.3 Janus Capital Corp. 1.9 Northern Trust Corp. 1.7 State Street Corp. 2.9 Vanguard Group Inc. 2 Wellington Management Co. 1.4 Wells Fargo & Co. 1.9	Brands name items photo compare the prices Kyphon Ethishop Medical Research Group Ethishop Medtronic Ethishop MiniMed Ethishop Vitatron Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF MEDTRONIC , group and subsidiaries [?] 7% Job: 7% of company's jobs cut since 1998 2 Delinquency: 2 act(s) of financial or trade delinquency 9 Tax haven, secret bank account, shell companies: operates in 9 offshore financial center(s) 5 Net profit: more than 5 billion(s) dollars/euros in cumulated net profit since 1998 322 Top management: earns 322 times the median income in the United States (32000 US$/year) Full profile >>>
Relevance: business & market share year business source 2006 World's second-largest medical equipment maker. Les Echos World locations & Manufacturing country incentive : address & contact : production type source Arterial Vascular Engineering International Sales, Inc : Medtronic Functional Diagnostics Asia Ltd : Sofamor Danek Asia Pacific Ltd : AVE Cayman Islands, Ltd : Merocel Foreign Sales Corp : Medtronic Ireland Ltd : Bard Connaught : AVE Ireland Ltd : Medtronic Mediterranean SAL : Milu S.A : Sofamor Danek Benelux, S.A : Synectics IR SA : Arterial Vascular Engineering PTE. LTD : Medtronic (S) Pte., Ltd : Sofamor Danek Singapore PTE, Ltd : Medtronic (Schweiz) A.G : Vitatron AG : Medtronic Europe S.A : Arterial Vascular Engineering (Schweiz) AG : The map of tax haven, secret accounts and shell companies Medtronic is managed by year name photo position; compensation source 2003Collins Jr, Arthur Chief Executive Officer; salary: 4.45 million US$; stock-options: 1.58 million US$; 2003Hawkins, William Chairman; salary: 0.71 million US$; 2003Mahle, Stephen Vice-president; salary: 1.01 million US$; stock-options: 1.1 million US$; 2003Ryan, Robert Chief Financial Officer; salary: 0.51 million US$; stock-options: 2.53 million US$; 2003Ward, Scott Chairman; 2002Douglas, Frank L Director; 2001George, William W Chief Executive Officer; salary: 1.9 million US$; stock-options: 8.4 million US$; 1998George, William W Chief Executive Officer; salary: 2.58 million US$; Forbes Highest paid executives in 2007

Made by year employees <> social impact : country source 2003 30000 2002 26050 1999 -700 Reuters 1999 -1600 Reuters 1998 12466 Layoff plans and labour conditions in 2007 Financials year financial misdemeanor sales income buyback source 2007 The Council of competition sanctions five cardiac defibrillator manufacturers to a 2,6 million euros fine for refusing, in a concerted way, to answer the national invitation to tender concerning the supply as defibrillator organized by 17 hospitals. The five suppliers met on several occasions to discuss the action to be taken vis-a-vis with this national invitation to tender and acted in concert to lead to a common decision of refusal to answer the invitation to tender. A horizontal agreement as regards public market is serious by nature, independently of the importance of the affected market and the duration of this assignment, since it aims to prevent the process of competition. Specifically, the practices of companies resulted in ruining the first national invitation to tender on a grouped purchase of medical devices. This failure prevented the hospitals from profiting from a rationalization of their purchases and a fall of price and resulted in not renewing this type of invitation to tender thereafter. The sanctions are as follows: Biotronik: 200 000 euros; Guiding: 400 000 euros; Medical ELA: 500 000 euros; Medtronic: 1,1 million euros; Medical Jude Saint: 450 000 euros.     2007   50 million shares 2005   0.04 billion US$ 2005 Received a subpoena in a U.S. probe into agreements between replacement knee and hip makers and surgeons, faces investigations of payments to doctors using their products, possible improper product promotion.     Bloomberg 2004   30 million shares Philadelph. 2003   7.67 1.6   billion US$ 2003   25 million shares Philadelph. 2002   6.41 0.98   billion US$ 2001   5.55 1.05   billion US$ 2000   5.01 1.1   billion US$ 1998   4.13 0.47   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Aig american group   AIG's Loss, Capital Needs Renew Doubts About Sullivan's Tenure - Friday 9 May 2008 at 08h30

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

All comments